Corindus Vascular Robotics Company Profile (NYSEMKT:CVRS)

About Corindus Vascular Robotics (NYSEMKT:CVRS)

Corindus Vascular Robotics logoCorindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The Company's CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NYSEMKT:CVRS
  • CUSIP: N/A
  • Web: www.corindus.com
Capitalization:
  • Market Cap: $217.01 million
  • Outstanding Shares: 187,080,000
Average Prices:
  • 50 Day Moving Avg: $1.21
  • 200 Day Moving Avg: $0.91
  • 52 Week Range: $0.40 - $1.80
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.11
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.51 million
  • Price / Sales: 86.46
  • Book Value: $0.21 per share
  • Price / Book: 5.52
Profitability:
  • EBIDTA: ($33,770,000.00)
Misc:
  • Average Volume: 945,220 shs.
  • Beta: 0.89
  • Short Ratio: 16.14
 

Frequently Asked Questions for Corindus Vascular Robotics (NYSEMKT:CVRS)

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "CVRS."

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEMKT:CVRS) issued its earnings results on Tuesday, May, 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.02. The firm had revenue of $0.78 million for the quarter, compared to analysts' expectations of $1.59 million. View Corindus Vascular Robotics' Earnings History.

Where is Corindus Vascular Robotics' stock going? Where will Corindus Vascular Robotics' stock price be in 2017?

1 equities research analysts have issued 1 year target prices for Corindus Vascular Robotics' stock. Their forecasts range from $3.00 to $3.00. On average, they expect Corindus Vascular Robotics' stock price to reach $3.00 in the next year. View Analyst Ratings for Corindus Vascular Robotics.

Who are some of Corindus Vascular Robotics' key competitors?

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the folowing people:

  • Jeffrey C. Lightcap, Independent Chairman of the Board
  • Mark J. Toland, President, Chief Executive Officer, Director
  • David W. Long, Chief Financial Officer, Senior Vice President, Treasurer, Secretary
  • Louis A. Cannon M.D., Director
  • Gerard Winkels, Director
  • Hillel Bachrach, Independent Director
  • Jeffrey Gold, Independent Director
  • Michael Y. Mashaal M.D., Independent Director

Who owns Corindus Vascular Robotics stock?

Corindus Vascular Robotics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (5.31%), Vanguard Group Inc. (1.75%), Wellington Management Group LLP (0.77%), Laurion Capital Management LP (0.68%), Geode Capital Management LLC (0.57%) and Morgan Stanley (0.42%). Company insiders that own Corindus Vascular Robotics stock include Healthcor Management, LP, Jeffrey Gold and Louis A Cannon. View Institutional Ownership Trends for Corindus Vascular Robotics.

Who sold Corindus Vascular Robotics stock? Who is selling Corindus Vascular Robotics stock?

Corindus Vascular Robotics' stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Laurion Capital Management LP and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Corindus Vascular Robotics.

Who bought Corindus Vascular Robotics stock? Who is buying Corindus Vascular Robotics stock?

Corindus Vascular Robotics' stock was purchased by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Schwab Charles Investment Management Inc., Vanguard Group Inc. and Bank of New York Mellon Corp. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Healthcor Management, LP, Jeffrey Gold and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

How do I buy Corindus Vascular Robotics stock?

Shares of Corindus Vascular Robotics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of Corindus Vascular Robotics stock can currently be purchased for approximately $1.16.


MarketBeat Community Rating for Corindus Vascular Robotics (NYSEMKT CVRS)
Community Ranking:  1.6 out of 5 ()
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Corindus Vascular Robotics (NYSEMKT:CVRS) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00

Analysts' Ratings History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Show:
DateFirmActionRatingPrice TargetDetails
5/15/2017B. RileyReiterated RatingBuy$3.00View Rating Details
4/20/2016Sterne Agee CRTReiterated RatingBuy$3.00View Rating Details
1/19/2016Stifel NicolausLower Price TargetBuy$6.00 -> $4.00View Rating Details
6/23/2015Cowen and CompanyInitiated CoverageOutperform$5.25View Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Earnings by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Earnings History by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.05)($0.07)$1.59 million$0.78 millionViewListenView Earnings Details
3/15/2017Q4 2016($0.07)($0.08)$0.73 million$0.54 millionViewN/AView Earnings Details
11/8/2016Q316($0.06)($0.07)$1.27 million$0.69 millionViewListenView Earnings Details
3/8/2016Q415($0.05)($0.06)$0.62 million$0.83 millionViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)$0.70 million$0.21 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Corindus Vascular Robotics (NYSEMKT:CVRS)
Current Year EPS Consensus Estimate: $-0.24 EPS
Next Year EPS Consensus Estimate: $-0.19 EPS

Dividends

Dividend History for Corindus Vascular Robotics (NYSEMKT:CVRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Insider Trades by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Insider Trades by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/22/2017Louis A CannonDirectorBuy27,000$1.30$35,100.00View SEC Filing  
2/28/2017Healthcor Management, L.P.Major ShareholderBuy7,557,436$0.66$4,987,907.76View SEC Filing  
11/25/2016Jeffrey GoldDirectorBuy10,000$0.76$7,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Corindus Vascular Robotics (NYSEMKT:CVRS)
Latest Headlines for Corindus Vascular Robotics (NYSEMKT:CVRS)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : May 26, 2017
finance.yahoo.com - May 26 at 5:08 PM
finance.yahoo.com logoCorindus to Present at the 18th Annual B. Riley Co. Investor Conference
finance.yahoo.com - May 17 at 4:40 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 16 at 6:26 PM
finance.yahoo.com logoPRECISION Registry Data on Robotic-Assisted PCI Presented During Late Breaking Clinical Trial Session at SCAI 2017
finance.yahoo.com - May 16 at 12:10 PM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : May 15, 2017
finance.yahoo.com - May 15 at 4:28 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Rating Reiterated by B. Riley
www.americanbankingnews.com - May 14 at 10:14 PM
finance.yahoo.com logoCorindus Vascular Robotics, Inc. :CVRS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 5:07 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - May 10 at 12:53 PM
finance.yahoo.com logoCorindus Vascular Robotics Reports First Quarter 2017 Results
finance.yahoo.com - May 9 at 4:34 PM
finance.yahoo.com logoCorindus to Feature CorPath® GRX System at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions
finance.yahoo.com - May 4 at 9:10 AM
finance.yahoo.com logoCorindus Announces 100th Robotic-Assisted PCI Procedure Performed Using 2nd Generation CorPath® GRX System
finance.yahoo.com - May 2 at 12:23 PM
finance.yahoo.com logoCorindus Announces Live Broadcast of Robotic-assisted PCI using CorPath® GRX to TCT Asia-Pacific Summit in South Korea
finance.yahoo.com - April 27 at 1:54 AM
americanbankingnews.com logoCorindus Vascular Robotics (CVRS) Getting Somewhat Positive Press Coverage, Analysis Finds
www.americanbankingnews.com - April 25 at 7:28 PM
finance.yahoo.com logoCorindus Announces Strategic Partnership with BLOXR Solutions to Distribute Line of Radiation Protection Products
finance.yahoo.com - April 25 at 11:58 AM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : April 24, 2017
finance.yahoo.com - April 24 at 4:28 PM
americanbankingnews.com logoCorindus Vascular Robotics (CVRS) Receiving Favorable News Coverage, Analysis Shows
www.americanbankingnews.com - April 22 at 2:49 PM
finance.yahoo.com logoCorindus Vascular Robotics to Report First Quarter 2017 Financial Results on May 9, 2017
finance.yahoo.com - April 21 at 4:42 PM
News IconBRIEF-Corindus Vascular Robotics offering and resale by selling stockholders of 68.1 mln shares
www.businessinsider.com - April 18 at 12:10 PM
americanbankingnews.com logoCorindus Vascular Robotics (CVRS) Receives Coverage Optimism Score of 0.36
www.americanbankingnews.com - April 17 at 2:58 PM
americanbankingnews.com logoCorindus Vascular Robotics (CVRS) Getting Somewhat Critical Media Coverage, Study Shows
www.americanbankingnews.com - April 13 at 12:08 PM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 4:33 PM
businesswire.com logoCorindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath ® GRX System
www.businesswire.com - March 31 at 9:58 PM
finance.yahoo.com logoCorindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath® GRX System
au.finance.yahoo.com - March 31 at 4:43 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Director Louis A. Cannon Purchases 27,000 Shares
www.americanbankingnews.com - March 23 at 10:37 PM
americanbankingnews.com logoZacks Investment Research Lowers Corindus Vascular Robotics Inc (CVRS) to Hold
www.americanbankingnews.com - March 22 at 5:28 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Rating Increased to Buy at B. Riley
www.americanbankingnews.com - March 22 at 11:43 AM
americanbankingnews.com logoCorindus Vascular Robotics’ (CVRS) “Buy” Rating Reiterated at B. Riley
www.americanbankingnews.com - March 19 at 11:03 AM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - March 16 at 6:50 PM
finance.yahoo.com logoCorindus Vascular Robotics Announces Closing of Private Placement for $45 Million
finance.yahoo.com - March 16 at 5:58 PM
seekingalpha.com logoCorindus Vascular Robotics' (CVRS) CEO Mark Toland on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 16 at 3:05 AM
nasdaq.com logoCorindus Vascular Robotics (CVRS) Jumps: Stock Gains 19.5% - Nasdaq
www.nasdaq.com - March 15 at 10:03 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Reports Fourth Quarter and Full Year 2016 Results
us.rd.yahoo.com - March 15 at 5:02 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
us.rd.yahoo.com - March 15 at 5:02 PM
seekingalpha.com logoCorindus Vascular Robotics teams up with WakeMed Health to develop national center excellence on robotic-assisted PCI; shares ahead 13% premarket
seekingalpha.com - March 15 at 9:59 AM
finance.yahoo.com logoCorindus Announces Partnership with WakeMed Health & Hospitals
finance.yahoo.com - March 15 at 9:59 AM
biz.yahoo.com logoQ4 2016 Corindus Vascular Robotics Inc Earnings Release - After Market Close
biz.yahoo.com - March 15 at 9:59 AM
finance.yahoo.com logoCorindus Vascular Robotics (CVRS) Jumps: Stock Gains 19.5%
finance.yahoo.com - March 15 at 9:59 AM
reuters.com logoBRIEF-Hudson Executive Capital reports 6.1 pct stake in Corindus Vascular Robotics
www.reuters.com - March 10 at 5:41 PM
seekingalpha.com logoCorindus Vascular Robotics (CVRS) Presents At Cowen and Company 37th Annual Health Care Conference
seekingalpha.com - March 8 at 5:22 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 8 at 5:22 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of
biz.yahoo.com - March 1 at 6:16 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath® GRX System in Japan
us.rd.yahoo.com - February 16 at 1:37 PM
streetinsider.com logoCorindus Vascular Robotics (CVRS) Enters Strategic Distribution Partnership with MC Healthcare Group
www.streetinsider.com - February 16 at 1:37 PM
businesswire.com logoCorindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath ® GRX System in Japan
www.businesswire.com - February 16 at 1:37 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - February 16 at 1:37 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Announces First Commercial Procedures Performed Using CorPath® GRX System
us.rd.yahoo.com - February 10 at 4:59 PM
us.rd.yahoo.com logo6:46 am Corindus Vascular Robotics announces that the first commercial procedures have been performed using its CorPath GRX System
us.rd.yahoo.com - February 10 at 4:59 PM
reuters.com logoBRIEF-Corindus Vascular Robotics sees FY 2017 revenue $13 mln-$15 mln
www.reuters.com - January 17 at 5:29 PM
finance.yahoo.com logoCorindus Vascular Robotics Announces Business Accomplishments for Fourth Quarter and Full Year 2016 and Updates 2017 Financial Guidance
finance.yahoo.com - January 17 at 5:29 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - January 17 at 5:29 PM

Social

This page was last updated on 5/29/2017 by MarketBeat.com Staff